Medtech maker Domain Surgical closed an equity funding round with $11.6 million raised from 10 investors, SEC filings show.
Funding Roundup
Medtech funding for the week of Mar. 3, 2014
EarLens pulls in $36M for infrared hearing aid
March 3, 2014 by Brad Perriello
EarLens said it raised some $36 million in an equity round for the hearing aid technology it’s developing that uses infrared rather than sound waves.
Biomet announces IPO plans
Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.
A group of private PE players including the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts and TPG acquired Biomet for $11.4 billion in 2007, placing medtech veteran Jeffrey Binder at the helm.
Hitachi, Omega Medical land $28M in DoD radiology deals
Respiratory Motion raises $6M, touts results from ventilation monitoring study
Respiratory Motion is on a roll, landing nearly $6 million in new funding and unveiling positive results from a clinical study of its ExSpiron non-invasive respiratory monitor.
The Waltham, Mass.-based hopes to close the Series B round with $8.8 million, having raised $5.8 million so far from lead investor Easton Capital and other existing investors. The funds are slated to support sales and marketing efforts for the ExSpiron system, the company said.
Lumicell adds another $600,000 in funding
Imaging systems maker Lumicell Diagnostics amended a previously closed $1 million funding round after landing another $560,000 in financing from 2 new investors, regulatory filings show.
Surgical lighting company Invuity lands $36M Series E round
San Francisco surgical lighting company Invuity Inc. secured $36 million in a Series E funding round, planning on using the new cash to "accelerate commercial initiatives."
Stealthy BioTrace Medical reels in $3.4M
BioTrace Medical is closing in on its $3.5 million goal, having raised $3.4 million in a funding round, according to a regulatory filing.
BioTrace, which is backed by early-stage medtech angel Xandex Investments, is developing a temporary cardiac pacing device to treat reversible symptomatic bradycardia.
Bruin Biometrics brings in $10M
Bruin Biometrics said it closed an oversubscribed funding round that beat its target by nearly $2.7 million.
The Los Angeles-based company, which makes biometric sensors designed to detect tissue damage in wounds, joints and orthopedic implants, said the $10 million round came in well aboce its goal.
NxThera closes $20M Series C round
NxThera said it closed a $20 million Series C round that topped its initial $18 million target.
Maple Grove, Minn.-based NxThera won CE Mark approval in the European Union last August for its Rezūm prostate device, which uses steam to reduce the size of the prostate to relieve urinary symptoms from benign prostate hyperplasia.
Cheetah Medical closes $9M funding round
Cheetah Medical said it added another $9 million to its coffers in a funding round led by Fletcher Spaght Ventures.
The Newton, Mass.-based medical device company, which makes a non-invasive hemodynamic monitoring system, said Springfield Investment Management, MVM Life Science Partners, Robert Bosch Venture Capital and Ascension Health Ventures also participated in the round.